LobbyingFlorida Essential Healthcare Partnerships lobbying by quarter
Florida Essential Healthcare Partnerships's latest lobbying report covers Q4 2025, at $105K. The four quarters Q4 2025–Q3 2026 total $105K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Florida Essential Healthcare Partnerships
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $105K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $60K | 1 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 2 |
| Q2 2024 | $60K | 1 |
| Q3 2024 | $60K | 1 |
| Q4 2024 | $60K | 1 |
| Q1 2025 | $105K | 1 |
| Q2 2025 | $105K | 1 |
| Q3 2025 | $105K | 1 |
| Q4 2025 | $105K | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$420K · 8 reports
- Health issues$315K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES8 reports
- SENATE4 reports
- Executive Office of the President (EOP)3 reports
- Health & Human Services, Dept of (HHS)1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Continental Strategy | $420K | 4 quarters |
| Baker Donelson Bearman Caldwell & Berkowitz | $340K | 6 quarters |
| DB3 | $200K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| THOMAS DASCHLE | Former United States Senator | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/19for Q4 2025 | Continental Strategy | $105K |
| 25/10/20for Q3 2025 | Continental Strategy | $105K |
| 25/07/21for Q2 2025 | Continental Strategy | $105K |
| 25/04/16for Q1 2025 | Continental Strategy | $105K |
| 25/01/21for Q4 2024 | DB3 | $60K |
| 25/01/16for Q1 2025 | Continental Strategy | Under $5,000 |
| 24/10/21for Q3 2024 | DB3 | $60K |
| 24/07/19for Q2 2024 | DB3 | $60K |
| 24/04/20for Q1 2024 | DB3 | $20K |
| 24/03/14for Q1 2024 | DB3 | Under $5,000 |
| 24/03/05for Q1 2024 | Baker Donelson Bearman Caldwell & Berkowitz | $40K |
| 24/01/21for Q4 2023 | Baker Donelson Bearman Caldwell & Berkowitz | $60K |
| 23/10/13for Q3 2023 | Baker Donelson Bearman Caldwell & Berkowitz | $60K |
| 23/07/14for Q2 2023 | Baker Donelson Bearman Caldwell & Berkowitz | $60K |
| 23/04/18for Q1 2023 | Baker Donelson Bearman Caldwell & Berkowitz | $60K |
| 23/01/19for Q4 2022 | Baker Donelson Bearman Caldwell & Berkowitz | $60K |